开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2180719, encodeId=85052180e1967, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;临床 经验分享：一篇手术方式相关的meta分析，投稿6个月后接收。整个过程很漫长，从格式审核，寻找编辑，寻找审稿人时间都很长，导致心力交瘁。期间给编辑部发过4次催稿信，回复都很类似，告诉会尽快安排审稿。投稿五月一审才回来，审稿人一个拒稿，一个小修，修改后最终接收。个人经验，如果着急不建议投该杂志；但能送外审的话，接收率还挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Jan 11 10:05:46 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2225232, encodeId=81f92225232ff, content=偏重的研究方向：诊断;clinical;癌症 经验分享：一审意见已经返回两周了，今天导师给编辑发了催稿信，希望能快点处理吧😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a6f9016255, createdName=ms9000000051824319, createdTime=Wed Sep 11 15:58:53 CST 2024, time=2024-09-11, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2208765, encodeId=67172208e6529, content=偏重的研究方向：肿瘤;临床 经验分享：1月5日 peer review到现在5个月状态一直没变中途写邮件问，回复说在努力寻找审稿人..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2115690790, createdName=ms5000000721393428, createdTime=Fri Jun 07 10:24:45 CST 2024, time=2024-06-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2223131, encodeId=ea6d222313176, content=太慢了，3个多月了，还在With editor , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a40c8345293, createdName=ms3000001689807175, createdTime=Thu Aug 29 22:52:35 CST 2024, time=2024-08-29, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143493, encodeId=a16e21434934c, content=偏重的研究方向：肺癌;乳腺癌;肿瘤免疫 经验分享：2023年3月20号投稿的，5月16号两个审稿意见都回来了，都是小修，5月30号修回，到现在没啥消息，心累, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef685682178, createdName=ms2000001828535543, createdTime=Sun Jun 18 12:41:51 CST 2023, time=2023-06-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1012596, encodeId=f2f71012596a4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：第一次感受到审稿这么快的，一个月内找到两个审稿人，一个基本上是直接接收，一个给的小修，反修后大概过了23天，今天刚刚接收，这是比较顺利的一次投稿。关于肺癌一种类型的发病率和预后情况，写作比较常规。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/c69458c5aae644fca7458ac4ee7d3dc5/97598ec05e2943409cd351605fd99203.jpg, createdBy=75b92509278, createdName=胸外科小辣鸡, createdTime=Sun Aug 29 16:55:52 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222496, encodeId=4186222249695, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：6.13投稿 6.14通过技术审查 6.14with editor 到现在中途催稿两次都说在帮我找编辑好好好这个杂志真的教我做人了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e99331389, createdName=ms8000001072402810, createdTime=Mon Aug 26 16:40:49 CST 2024, time=2024-08-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2223081, encodeId=8e25222308179, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Submission history Submission received Submission status Date Submission received 10 Nov 2023 Technical check Submission status Date Submission is under technical check 10 Nov 2023 Amendment requested 16 Nov 2023 Amendment received 17 Nov 2023 Amendment requested 23 Nov 2023 Amendment received 23 Nov 2023 Submission passed technical check 23 Nov 2023 Editorial assignment Submission status Date Ready for editorial assignment 23 Nov 2023 With editor Submission status Date Editor assigned 05 Jan 2024 Peer review Submission status Date First reviewer(s) invited 10 Jan 2024 Reviewer(s) accepted 12 Mar 2024 Reviewer report(s) received 16 Mar 2024 Revision requested 23 May 2024 Revision received 06 Jun 2024 Submission passed technical check 06 Jun 2024 First reviewer(s) invited 20 Jun 2024 Reviewer(s) accepted 08 Jul 2024 Reviewer report(s) received 23 Jul 2024 Revision requested 31 Jul 2024 Revision received 13 Aug 2024 Submission passed technical check 13 Aug 2024 Submission accepted Submission status Date Submission accepted 22 Aug 2024 Publishing and rights Submission status Date Submission is in publishing and rights, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Thu Aug 29 19:39:14 CST 2024, time=2024-08-29, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2223148, encodeId=8ad92223148e4, content=偏重的研究方向：肿瘤;食管癌 经验分享：The editor has received 2 reviewer report(s). 快一个月了，handing editor仍然没有做决定，各位有遇到过么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49f63034913, createdName=wangle9206, createdTime=Fri Aug 30 08:38:33 CST 2024, time=2024-08-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2221574, encodeId=7cdc22215e4fe, content=和大家分享一下，互勉 Submission history Submission received Submission status Date Submission received 22 Jan 2024 Technical check Submission status Date Submission is under technical check 22 Jan 2024 Amendment requested 01 Feb 2024 Amendment received 04 Feb 2024 Amendment requested 05 Feb 2024 Amendment received 08 Feb 2024 Submission passed technical check 12 Feb 2024 Editorial assignment Submission status Date Ready for editorial assignment 12 Feb 2024 With editor Submission status Date Editor assigned 12 Feb 2024 Peer review Submission status Date Reviewer(s) invited 23 Apr 2024 Reviewer(s) accepted 13 Jun 2024 Reviewer report(s) received 23 Jun 2024 Revision requested 07 Jul 2024 Revision received 18 Jul 2024 Submission passed technical check 19 Jul 2024 Reviewer(s) invited 24 Jul 2024 Reviewer(s) accepted 25 Jul 2024 Reviewer report(s) received 04 Aug 2024 Revision requested 05 Aug 2024 Revision received 09 Aug 2024 Submission passed technical check 09 Aug 2024 Reviewer(s) invited 11 Aug 2024 Reviewer(s) accepted 12 Aug 2024 Reviewer report(s) received 15 Aug 2024 Submission accepted Submission status Date Submission accepted 20 Aug 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TnBzsnIeibbibHtAcOogpwCUlK1FveaYBDibBmqrXZMdqc1mJHUXyrj8H988HwqdAUU2Q/132, createdBy=2afc101603, createdName=cat709394, createdTime=Tue Aug 20 18:32:29 CST 2024, time=2024-08-20, status=1, ipAttribution=辽宁)]

2024-01-11 ms9000001935138113 来自北京

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤;临床
经验分享：一篇手术方式相关的meta分析，投稿6个月后接收。整个过程很漫长，从格式审核，寻找编辑，寻找审稿人时间都很长，导致心力交瘁。期间给编辑部发过4次催稿信，回复都很类似，告诉会尽快安排审稿。投稿五月一审才回来，审稿人一个拒稿，一个小修，修改后最终接收。个人经验，如果着急不建议投该杂志；但能送外审的话，接收率还挺高的。

62 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2180719, encodeId=85052180e1967, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;临床 经验分享：一篇手术方式相关的meta分析，投稿6个月后接收。整个过程很漫长，从格式审核，寻找编辑，寻找审稿人时间都很长，导致心力交瘁。期间给编辑部发过4次催稿信，回复都很类似，告诉会尽快安排审稿。投稿五月一审才回来，审稿人一个拒稿，一个小修，修改后最终接收。个人经验，如果着急不建议投该杂志；但能送外审的话，接收率还挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Jan 11 10:05:46 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2225232, encodeId=81f92225232ff, content=偏重的研究方向：诊断;clinical;癌症 经验分享：一审意见已经返回两周了，今天导师给编辑发了催稿信，希望能快点处理吧😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a6f9016255, createdName=ms9000000051824319, createdTime=Wed Sep 11 15:58:53 CST 2024, time=2024-09-11, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2208765, encodeId=67172208e6529, content=偏重的研究方向：肿瘤;临床 经验分享：1月5日 peer review到现在5个月状态一直没变中途写邮件问，回复说在努力寻找审稿人..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2115690790, createdName=ms5000000721393428, createdTime=Fri Jun 07 10:24:45 CST 2024, time=2024-06-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2223131, encodeId=ea6d222313176, content=太慢了，3个多月了，还在With editor , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a40c8345293, createdName=ms3000001689807175, createdTime=Thu Aug 29 22:52:35 CST 2024, time=2024-08-29, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143493, encodeId=a16e21434934c, content=偏重的研究方向：肺癌;乳腺癌;肿瘤免疫 经验分享：2023年3月20号投稿的，5月16号两个审稿意见都回来了，都是小修，5月30号修回，到现在没啥消息，心累, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef685682178, createdName=ms2000001828535543, createdTime=Sun Jun 18 12:41:51 CST 2023, time=2023-06-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1012596, encodeId=f2f71012596a4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：第一次感受到审稿这么快的，一个月内找到两个审稿人，一个基本上是直接接收，一个给的小修，反修后大概过了23天，今天刚刚接收，这是比较顺利的一次投稿。关于肺癌一种类型的发病率和预后情况，写作比较常规。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/c69458c5aae644fca7458ac4ee7d3dc5/97598ec05e2943409cd351605fd99203.jpg, createdBy=75b92509278, createdName=胸外科小辣鸡, createdTime=Sun Aug 29 16:55:52 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222496, encodeId=4186222249695, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：6.13投稿 6.14通过技术审查 6.14with editor 到现在中途催稿两次都说在帮我找编辑好好好这个杂志真的教我做人了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e99331389, createdName=ms8000001072402810, createdTime=Mon Aug 26 16:40:49 CST 2024, time=2024-08-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2223081, encodeId=8e25222308179, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Submission history Submission received Submission status Date Submission received 10 Nov 2023 Technical check Submission status Date Submission is under technical check 10 Nov 2023 Amendment requested 16 Nov 2023 Amendment received 17 Nov 2023 Amendment requested 23 Nov 2023 Amendment received 23 Nov 2023 Submission passed technical check 23 Nov 2023 Editorial assignment Submission status Date Ready for editorial assignment 23 Nov 2023 With editor Submission status Date Editor assigned 05 Jan 2024 Peer review Submission status Date First reviewer(s) invited 10 Jan 2024 Reviewer(s) accepted 12 Mar 2024 Reviewer report(s) received 16 Mar 2024 Revision requested 23 May 2024 Revision received 06 Jun 2024 Submission passed technical check 06 Jun 2024 First reviewer(s) invited 20 Jun 2024 Reviewer(s) accepted 08 Jul 2024 Reviewer report(s) received 23 Jul 2024 Revision requested 31 Jul 2024 Revision received 13 Aug 2024 Submission passed technical check 13 Aug 2024 Submission accepted Submission status Date Submission accepted 22 Aug 2024 Publishing and rights Submission status Date Submission is in publishing and rights, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Thu Aug 29 19:39:14 CST 2024, time=2024-08-29, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2223148, encodeId=8ad92223148e4, content=偏重的研究方向：肿瘤;食管癌 经验分享：The editor has received 2 reviewer report(s). 快一个月了，handing editor仍然没有做决定，各位有遇到过么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49f63034913, createdName=wangle9206, createdTime=Fri Aug 30 08:38:33 CST 2024, time=2024-08-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2221574, encodeId=7cdc22215e4fe, content=和大家分享一下，互勉 Submission history Submission received Submission status Date Submission received 22 Jan 2024 Technical check Submission status Date Submission is under technical check 22 Jan 2024 Amendment requested 01 Feb 2024 Amendment received 04 Feb 2024 Amendment requested 05 Feb 2024 Amendment received 08 Feb 2024 Submission passed technical check 12 Feb 2024 Editorial assignment Submission status Date Ready for editorial assignment 12 Feb 2024 With editor Submission status Date Editor assigned 12 Feb 2024 Peer review Submission status Date Reviewer(s) invited 23 Apr 2024 Reviewer(s) accepted 13 Jun 2024 Reviewer report(s) received 23 Jun 2024 Revision requested 07 Jul 2024 Revision received 18 Jul 2024 Submission passed technical check 19 Jul 2024 Reviewer(s) invited 24 Jul 2024 Reviewer(s) accepted 25 Jul 2024 Reviewer report(s) received 04 Aug 2024 Revision requested 05 Aug 2024 Revision received 09 Aug 2024 Submission passed technical check 09 Aug 2024 Reviewer(s) invited 11 Aug 2024 Reviewer(s) accepted 12 Aug 2024 Reviewer report(s) received 15 Aug 2024 Submission accepted Submission status Date Submission accepted 20 Aug 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TnBzsnIeibbibHtAcOogpwCUlK1FveaYBDibBmqrXZMdqc1mJHUXyrj8H988HwqdAUU2Q/132, createdBy=2afc101603, createdName=cat709394, createdTime=Tue Aug 20 18:32:29 CST 2024, time=2024-08-20, status=1, ipAttribution=辽宁)]

2024-09-11 ms9000000051824319 来自辽宁省

偏重的研究方向：诊断;clinical;癌症
经验分享：一审意见已经返回两周了，今天导师给编辑发了催稿信，希望能快点处理吧😭

6 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2180719, encodeId=85052180e1967, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;临床 经验分享：一篇手术方式相关的meta分析，投稿6个月后接收。整个过程很漫长，从格式审核，寻找编辑，寻找审稿人时间都很长，导致心力交瘁。期间给编辑部发过4次催稿信，回复都很类似，告诉会尽快安排审稿。投稿五月一审才回来，审稿人一个拒稿，一个小修，修改后最终接收。个人经验，如果着急不建议投该杂志；但能送外审的话，接收率还挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Jan 11 10:05:46 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2225232, encodeId=81f92225232ff, content=偏重的研究方向：诊断;clinical;癌症 经验分享：一审意见已经返回两周了，今天导师给编辑发了催稿信，希望能快点处理吧😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a6f9016255, createdName=ms9000000051824319, createdTime=Wed Sep 11 15:58:53 CST 2024, time=2024-09-11, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2208765, encodeId=67172208e6529, content=偏重的研究方向：肿瘤;临床 经验分享：1月5日 peer review到现在5个月状态一直没变中途写邮件问，回复说在努力寻找审稿人..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2115690790, createdName=ms5000000721393428, createdTime=Fri Jun 07 10:24:45 CST 2024, time=2024-06-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2223131, encodeId=ea6d222313176, content=太慢了，3个多月了，还在With editor , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a40c8345293, createdName=ms3000001689807175, createdTime=Thu Aug 29 22:52:35 CST 2024, time=2024-08-29, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143493, encodeId=a16e21434934c, content=偏重的研究方向：肺癌;乳腺癌;肿瘤免疫 经验分享：2023年3月20号投稿的，5月16号两个审稿意见都回来了，都是小修，5月30号修回，到现在没啥消息，心累, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef685682178, createdName=ms2000001828535543, createdTime=Sun Jun 18 12:41:51 CST 2023, time=2023-06-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1012596, encodeId=f2f71012596a4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：第一次感受到审稿这么快的，一个月内找到两个审稿人，一个基本上是直接接收，一个给的小修，反修后大概过了23天，今天刚刚接收，这是比较顺利的一次投稿。关于肺癌一种类型的发病率和预后情况，写作比较常规。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/c69458c5aae644fca7458ac4ee7d3dc5/97598ec05e2943409cd351605fd99203.jpg, createdBy=75b92509278, createdName=胸外科小辣鸡, createdTime=Sun Aug 29 16:55:52 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222496, encodeId=4186222249695, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：6.13投稿 6.14通过技术审查 6.14with editor 到现在中途催稿两次都说在帮我找编辑好好好这个杂志真的教我做人了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e99331389, createdName=ms8000001072402810, createdTime=Mon Aug 26 16:40:49 CST 2024, time=2024-08-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2223081, encodeId=8e25222308179, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Submission history Submission received Submission status Date Submission received 10 Nov 2023 Technical check Submission status Date Submission is under technical check 10 Nov 2023 Amendment requested 16 Nov 2023 Amendment received 17 Nov 2023 Amendment requested 23 Nov 2023 Amendment received 23 Nov 2023 Submission passed technical check 23 Nov 2023 Editorial assignment Submission status Date Ready for editorial assignment 23 Nov 2023 With editor Submission status Date Editor assigned 05 Jan 2024 Peer review Submission status Date First reviewer(s) invited 10 Jan 2024 Reviewer(s) accepted 12 Mar 2024 Reviewer report(s) received 16 Mar 2024 Revision requested 23 May 2024 Revision received 06 Jun 2024 Submission passed technical check 06 Jun 2024 First reviewer(s) invited 20 Jun 2024 Reviewer(s) accepted 08 Jul 2024 Reviewer report(s) received 23 Jul 2024 Revision requested 31 Jul 2024 Revision received 13 Aug 2024 Submission passed technical check 13 Aug 2024 Submission accepted Submission status Date Submission accepted 22 Aug 2024 Publishing and rights Submission status Date Submission is in publishing and rights, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Thu Aug 29 19:39:14 CST 2024, time=2024-08-29, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2223148, encodeId=8ad92223148e4, content=偏重的研究方向：肿瘤;食管癌 经验分享：The editor has received 2 reviewer report(s). 快一个月了，handing editor仍然没有做决定，各位有遇到过么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49f63034913, createdName=wangle9206, createdTime=Fri Aug 30 08:38:33 CST 2024, time=2024-08-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2221574, encodeId=7cdc22215e4fe, content=和大家分享一下，互勉 Submission history Submission received Submission status Date Submission received 22 Jan 2024 Technical check Submission status Date Submission is under technical check 22 Jan 2024 Amendment requested 01 Feb 2024 Amendment received 04 Feb 2024 Amendment requested 05 Feb 2024 Amendment received 08 Feb 2024 Submission passed technical check 12 Feb 2024 Editorial assignment Submission status Date Ready for editorial assignment 12 Feb 2024 With editor Submission status Date Editor assigned 12 Feb 2024 Peer review Submission status Date Reviewer(s) invited 23 Apr 2024 Reviewer(s) accepted 13 Jun 2024 Reviewer report(s) received 23 Jun 2024 Revision requested 07 Jul 2024 Revision received 18 Jul 2024 Submission passed technical check 19 Jul 2024 Reviewer(s) invited 24 Jul 2024 Reviewer(s) accepted 25 Jul 2024 Reviewer report(s) received 04 Aug 2024 Revision requested 05 Aug 2024 Revision received 09 Aug 2024 Submission passed technical check 09 Aug 2024 Reviewer(s) invited 11 Aug 2024 Reviewer(s) accepted 12 Aug 2024 Reviewer report(s) received 15 Aug 2024 Submission accepted Submission status Date Submission accepted 20 Aug 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TnBzsnIeibbibHtAcOogpwCUlK1FveaYBDibBmqrXZMdqc1mJHUXyrj8H988HwqdAUU2Q/132, createdBy=2afc101603, createdName=cat709394, createdTime=Tue Aug 20 18:32:29 CST 2024, time=2024-08-20, status=1, ipAttribution=辽宁)]

2024-06-07 ms5000000721393428 来自四川省

偏重的研究方向：肿瘤;临床
经验分享：1月5日 peer review到现在5个月状态一直没变中途写邮件问，回复说在努力寻找审稿人...

50 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2180719, encodeId=85052180e1967, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;临床 经验分享：一篇手术方式相关的meta分析，投稿6个月后接收。整个过程很漫长，从格式审核，寻找编辑，寻找审稿人时间都很长，导致心力交瘁。期间给编辑部发过4次催稿信，回复都很类似，告诉会尽快安排审稿。投稿五月一审才回来，审稿人一个拒稿，一个小修，修改后最终接收。个人经验，如果着急不建议投该杂志；但能送外审的话，接收率还挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Jan 11 10:05:46 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2225232, encodeId=81f92225232ff, content=偏重的研究方向：诊断;clinical;癌症 经验分享：一审意见已经返回两周了，今天导师给编辑发了催稿信，希望能快点处理吧😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a6f9016255, createdName=ms9000000051824319, createdTime=Wed Sep 11 15:58:53 CST 2024, time=2024-09-11, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2208765, encodeId=67172208e6529, content=偏重的研究方向：肿瘤;临床 经验分享：1月5日 peer review到现在5个月状态一直没变中途写邮件问，回复说在努力寻找审稿人..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2115690790, createdName=ms5000000721393428, createdTime=Fri Jun 07 10:24:45 CST 2024, time=2024-06-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2223131, encodeId=ea6d222313176, content=太慢了，3个多月了，还在With editor , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a40c8345293, createdName=ms3000001689807175, createdTime=Thu Aug 29 22:52:35 CST 2024, time=2024-08-29, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143493, encodeId=a16e21434934c, content=偏重的研究方向：肺癌;乳腺癌;肿瘤免疫 经验分享：2023年3月20号投稿的，5月16号两个审稿意见都回来了，都是小修，5月30号修回，到现在没啥消息，心累, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef685682178, createdName=ms2000001828535543, createdTime=Sun Jun 18 12:41:51 CST 2023, time=2023-06-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1012596, encodeId=f2f71012596a4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：第一次感受到审稿这么快的，一个月内找到两个审稿人，一个基本上是直接接收，一个给的小修，反修后大概过了23天，今天刚刚接收，这是比较顺利的一次投稿。关于肺癌一种类型的发病率和预后情况，写作比较常规。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/c69458c5aae644fca7458ac4ee7d3dc5/97598ec05e2943409cd351605fd99203.jpg, createdBy=75b92509278, createdName=胸外科小辣鸡, createdTime=Sun Aug 29 16:55:52 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222496, encodeId=4186222249695, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：6.13投稿 6.14通过技术审查 6.14with editor 到现在中途催稿两次都说在帮我找编辑好好好这个杂志真的教我做人了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e99331389, createdName=ms8000001072402810, createdTime=Mon Aug 26 16:40:49 CST 2024, time=2024-08-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2223081, encodeId=8e25222308179, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Submission history Submission received Submission status Date Submission received 10 Nov 2023 Technical check Submission status Date Submission is under technical check 10 Nov 2023 Amendment requested 16 Nov 2023 Amendment received 17 Nov 2023 Amendment requested 23 Nov 2023 Amendment received 23 Nov 2023 Submission passed technical check 23 Nov 2023 Editorial assignment Submission status Date Ready for editorial assignment 23 Nov 2023 With editor Submission status Date Editor assigned 05 Jan 2024 Peer review Submission status Date First reviewer(s) invited 10 Jan 2024 Reviewer(s) accepted 12 Mar 2024 Reviewer report(s) received 16 Mar 2024 Revision requested 23 May 2024 Revision received 06 Jun 2024 Submission passed technical check 06 Jun 2024 First reviewer(s) invited 20 Jun 2024 Reviewer(s) accepted 08 Jul 2024 Reviewer report(s) received 23 Jul 2024 Revision requested 31 Jul 2024 Revision received 13 Aug 2024 Submission passed technical check 13 Aug 2024 Submission accepted Submission status Date Submission accepted 22 Aug 2024 Publishing and rights Submission status Date Submission is in publishing and rights, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Thu Aug 29 19:39:14 CST 2024, time=2024-08-29, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2223148, encodeId=8ad92223148e4, content=偏重的研究方向：肿瘤;食管癌 经验分享：The editor has received 2 reviewer report(s). 快一个月了，handing editor仍然没有做决定，各位有遇到过么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49f63034913, createdName=wangle9206, createdTime=Fri Aug 30 08:38:33 CST 2024, time=2024-08-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2221574, encodeId=7cdc22215e4fe, content=和大家分享一下，互勉 Submission history Submission received Submission status Date Submission received 22 Jan 2024 Technical check Submission status Date Submission is under technical check 22 Jan 2024 Amendment requested 01 Feb 2024 Amendment received 04 Feb 2024 Amendment requested 05 Feb 2024 Amendment received 08 Feb 2024 Submission passed technical check 12 Feb 2024 Editorial assignment Submission status Date Ready for editorial assignment 12 Feb 2024 With editor Submission status Date Editor assigned 12 Feb 2024 Peer review Submission status Date Reviewer(s) invited 23 Apr 2024 Reviewer(s) accepted 13 Jun 2024 Reviewer report(s) received 23 Jun 2024 Revision requested 07 Jul 2024 Revision received 18 Jul 2024 Submission passed technical check 19 Jul 2024 Reviewer(s) invited 24 Jul 2024 Reviewer(s) accepted 25 Jul 2024 Reviewer report(s) received 04 Aug 2024 Revision requested 05 Aug 2024 Revision received 09 Aug 2024 Submission passed technical check 09 Aug 2024 Reviewer(s) invited 11 Aug 2024 Reviewer(s) accepted 12 Aug 2024 Reviewer report(s) received 15 Aug 2024 Submission accepted Submission status Date Submission accepted 20 Aug 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TnBzsnIeibbibHtAcOogpwCUlK1FveaYBDibBmqrXZMdqc1mJHUXyrj8H988HwqdAUU2Q/132, createdBy=2afc101603, createdName=cat709394, createdTime=Tue Aug 20 18:32:29 CST 2024, time=2024-08-20, status=1, ipAttribution=辽宁)]

2024-08-29 ms3000001689807175 来自贵州省

太慢了，3个多月了，还在With editor

32 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2180719, encodeId=85052180e1967, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;临床 经验分享：一篇手术方式相关的meta分析，投稿6个月后接收。整个过程很漫长，从格式审核，寻找编辑，寻找审稿人时间都很长，导致心力交瘁。期间给编辑部发过4次催稿信，回复都很类似，告诉会尽快安排审稿。投稿五月一审才回来，审稿人一个拒稿，一个小修，修改后最终接收。个人经验，如果着急不建议投该杂志；但能送外审的话，接收率还挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Jan 11 10:05:46 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2225232, encodeId=81f92225232ff, content=偏重的研究方向：诊断;clinical;癌症 经验分享：一审意见已经返回两周了，今天导师给编辑发了催稿信，希望能快点处理吧😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a6f9016255, createdName=ms9000000051824319, createdTime=Wed Sep 11 15:58:53 CST 2024, time=2024-09-11, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2208765, encodeId=67172208e6529, content=偏重的研究方向：肿瘤;临床 经验分享：1月5日 peer review到现在5个月状态一直没变中途写邮件问，回复说在努力寻找审稿人..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2115690790, createdName=ms5000000721393428, createdTime=Fri Jun 07 10:24:45 CST 2024, time=2024-06-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2223131, encodeId=ea6d222313176, content=太慢了，3个多月了，还在With editor , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a40c8345293, createdName=ms3000001689807175, createdTime=Thu Aug 29 22:52:35 CST 2024, time=2024-08-29, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143493, encodeId=a16e21434934c, content=偏重的研究方向：肺癌;乳腺癌;肿瘤免疫 经验分享：2023年3月20号投稿的，5月16号两个审稿意见都回来了，都是小修，5月30号修回，到现在没啥消息，心累, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef685682178, createdName=ms2000001828535543, createdTime=Sun Jun 18 12:41:51 CST 2023, time=2023-06-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1012596, encodeId=f2f71012596a4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：第一次感受到审稿这么快的，一个月内找到两个审稿人，一个基本上是直接接收，一个给的小修，反修后大概过了23天，今天刚刚接收，这是比较顺利的一次投稿。关于肺癌一种类型的发病率和预后情况，写作比较常规。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/c69458c5aae644fca7458ac4ee7d3dc5/97598ec05e2943409cd351605fd99203.jpg, createdBy=75b92509278, createdName=胸外科小辣鸡, createdTime=Sun Aug 29 16:55:52 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222496, encodeId=4186222249695, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：6.13投稿 6.14通过技术审查 6.14with editor 到现在中途催稿两次都说在帮我找编辑好好好这个杂志真的教我做人了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e99331389, createdName=ms8000001072402810, createdTime=Mon Aug 26 16:40:49 CST 2024, time=2024-08-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2223081, encodeId=8e25222308179, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Submission history Submission received Submission status Date Submission received 10 Nov 2023 Technical check Submission status Date Submission is under technical check 10 Nov 2023 Amendment requested 16 Nov 2023 Amendment received 17 Nov 2023 Amendment requested 23 Nov 2023 Amendment received 23 Nov 2023 Submission passed technical check 23 Nov 2023 Editorial assignment Submission status Date Ready for editorial assignment 23 Nov 2023 With editor Submission status Date Editor assigned 05 Jan 2024 Peer review Submission status Date First reviewer(s) invited 10 Jan 2024 Reviewer(s) accepted 12 Mar 2024 Reviewer report(s) received 16 Mar 2024 Revision requested 23 May 2024 Revision received 06 Jun 2024 Submission passed technical check 06 Jun 2024 First reviewer(s) invited 20 Jun 2024 Reviewer(s) accepted 08 Jul 2024 Reviewer report(s) received 23 Jul 2024 Revision requested 31 Jul 2024 Revision received 13 Aug 2024 Submission passed technical check 13 Aug 2024 Submission accepted Submission status Date Submission accepted 22 Aug 2024 Publishing and rights Submission status Date Submission is in publishing and rights, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Thu Aug 29 19:39:14 CST 2024, time=2024-08-29, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2223148, encodeId=8ad92223148e4, content=偏重的研究方向：肿瘤;食管癌 经验分享：The editor has received 2 reviewer report(s). 快一个月了，handing editor仍然没有做决定，各位有遇到过么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49f63034913, createdName=wangle9206, createdTime=Fri Aug 30 08:38:33 CST 2024, time=2024-08-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2221574, encodeId=7cdc22215e4fe, content=和大家分享一下，互勉 Submission history Submission received Submission status Date Submission received 22 Jan 2024 Technical check Submission status Date Submission is under technical check 22 Jan 2024 Amendment requested 01 Feb 2024 Amendment received 04 Feb 2024 Amendment requested 05 Feb 2024 Amendment received 08 Feb 2024 Submission passed technical check 12 Feb 2024 Editorial assignment Submission status Date Ready for editorial assignment 12 Feb 2024 With editor Submission status Date Editor assigned 12 Feb 2024 Peer review Submission status Date Reviewer(s) invited 23 Apr 2024 Reviewer(s) accepted 13 Jun 2024 Reviewer report(s) received 23 Jun 2024 Revision requested 07 Jul 2024 Revision received 18 Jul 2024 Submission passed technical check 19 Jul 2024 Reviewer(s) invited 24 Jul 2024 Reviewer(s) accepted 25 Jul 2024 Reviewer report(s) received 04 Aug 2024 Revision requested 05 Aug 2024 Revision received 09 Aug 2024 Submission passed technical check 09 Aug 2024 Reviewer(s) invited 11 Aug 2024 Reviewer(s) accepted 12 Aug 2024 Reviewer report(s) received 15 Aug 2024 Submission accepted Submission status Date Submission accepted 20 Aug 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TnBzsnIeibbibHtAcOogpwCUlK1FveaYBDibBmqrXZMdqc1mJHUXyrj8H988HwqdAUU2Q/132, createdBy=2afc101603, createdName=cat709394, createdTime=Tue Aug 20 18:32:29 CST 2024, time=2024-08-20, status=1, ipAttribution=辽宁)]

2023-06-18 ms2000001828535543 来自江苏省

偏重的研究方向：肺癌;乳腺癌;肿瘤免疫
经验分享：2023年3月20号投稿的，5月16号两个审稿意见都回来了，都是小修，5月30号修回，到现在没啥消息，心累

72 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2180719, encodeId=85052180e1967, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;临床 经验分享：一篇手术方式相关的meta分析，投稿6个月后接收。整个过程很漫长，从格式审核，寻找编辑，寻找审稿人时间都很长，导致心力交瘁。期间给编辑部发过4次催稿信，回复都很类似，告诉会尽快安排审稿。投稿五月一审才回来，审稿人一个拒稿，一个小修，修改后最终接收。个人经验，如果着急不建议投该杂志；但能送外审的话，接收率还挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Jan 11 10:05:46 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2225232, encodeId=81f92225232ff, content=偏重的研究方向：诊断;clinical;癌症 经验分享：一审意见已经返回两周了，今天导师给编辑发了催稿信，希望能快点处理吧😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a6f9016255, createdName=ms9000000051824319, createdTime=Wed Sep 11 15:58:53 CST 2024, time=2024-09-11, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2208765, encodeId=67172208e6529, content=偏重的研究方向：肿瘤;临床 经验分享：1月5日 peer review到现在5个月状态一直没变中途写邮件问，回复说在努力寻找审稿人..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2115690790, createdName=ms5000000721393428, createdTime=Fri Jun 07 10:24:45 CST 2024, time=2024-06-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2223131, encodeId=ea6d222313176, content=太慢了，3个多月了，还在With editor , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a40c8345293, createdName=ms3000001689807175, createdTime=Thu Aug 29 22:52:35 CST 2024, time=2024-08-29, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143493, encodeId=a16e21434934c, content=偏重的研究方向：肺癌;乳腺癌;肿瘤免疫 经验分享：2023年3月20号投稿的，5月16号两个审稿意见都回来了，都是小修，5月30号修回，到现在没啥消息，心累, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef685682178, createdName=ms2000001828535543, createdTime=Sun Jun 18 12:41:51 CST 2023, time=2023-06-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1012596, encodeId=f2f71012596a4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：第一次感受到审稿这么快的，一个月内找到两个审稿人，一个基本上是直接接收，一个给的小修，反修后大概过了23天，今天刚刚接收，这是比较顺利的一次投稿。关于肺癌一种类型的发病率和预后情况，写作比较常规。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/c69458c5aae644fca7458ac4ee7d3dc5/97598ec05e2943409cd351605fd99203.jpg, createdBy=75b92509278, createdName=胸外科小辣鸡, createdTime=Sun Aug 29 16:55:52 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222496, encodeId=4186222249695, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：6.13投稿 6.14通过技术审查 6.14with editor 到现在中途催稿两次都说在帮我找编辑好好好这个杂志真的教我做人了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e99331389, createdName=ms8000001072402810, createdTime=Mon Aug 26 16:40:49 CST 2024, time=2024-08-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2223081, encodeId=8e25222308179, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Submission history Submission received Submission status Date Submission received 10 Nov 2023 Technical check Submission status Date Submission is under technical check 10 Nov 2023 Amendment requested 16 Nov 2023 Amendment received 17 Nov 2023 Amendment requested 23 Nov 2023 Amendment received 23 Nov 2023 Submission passed technical check 23 Nov 2023 Editorial assignment Submission status Date Ready for editorial assignment 23 Nov 2023 With editor Submission status Date Editor assigned 05 Jan 2024 Peer review Submission status Date First reviewer(s) invited 10 Jan 2024 Reviewer(s) accepted 12 Mar 2024 Reviewer report(s) received 16 Mar 2024 Revision requested 23 May 2024 Revision received 06 Jun 2024 Submission passed technical check 06 Jun 2024 First reviewer(s) invited 20 Jun 2024 Reviewer(s) accepted 08 Jul 2024 Reviewer report(s) received 23 Jul 2024 Revision requested 31 Jul 2024 Revision received 13 Aug 2024 Submission passed technical check 13 Aug 2024 Submission accepted Submission status Date Submission accepted 22 Aug 2024 Publishing and rights Submission status Date Submission is in publishing and rights, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Thu Aug 29 19:39:14 CST 2024, time=2024-08-29, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2223148, encodeId=8ad92223148e4, content=偏重的研究方向：肿瘤;食管癌 经验分享：The editor has received 2 reviewer report(s). 快一个月了，handing editor仍然没有做决定，各位有遇到过么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49f63034913, createdName=wangle9206, createdTime=Fri Aug 30 08:38:33 CST 2024, time=2024-08-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2221574, encodeId=7cdc22215e4fe, content=和大家分享一下，互勉 Submission history Submission received Submission status Date Submission received 22 Jan 2024 Technical check Submission status Date Submission is under technical check 22 Jan 2024 Amendment requested 01 Feb 2024 Amendment received 04 Feb 2024 Amendment requested 05 Feb 2024 Amendment received 08 Feb 2024 Submission passed technical check 12 Feb 2024 Editorial assignment Submission status Date Ready for editorial assignment 12 Feb 2024 With editor Submission status Date Editor assigned 12 Feb 2024 Peer review Submission status Date Reviewer(s) invited 23 Apr 2024 Reviewer(s) accepted 13 Jun 2024 Reviewer report(s) received 23 Jun 2024 Revision requested 07 Jul 2024 Revision received 18 Jul 2024 Submission passed technical check 19 Jul 2024 Reviewer(s) invited 24 Jul 2024 Reviewer(s) accepted 25 Jul 2024 Reviewer report(s) received 04 Aug 2024 Revision requested 05 Aug 2024 Revision received 09 Aug 2024 Submission passed technical check 09 Aug 2024 Reviewer(s) invited 11 Aug 2024 Reviewer(s) accepted 12 Aug 2024 Reviewer report(s) received 15 Aug 2024 Submission accepted Submission status Date Submission accepted 20 Aug 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TnBzsnIeibbibHtAcOogpwCUlK1FveaYBDibBmqrXZMdqc1mJHUXyrj8H988HwqdAUU2Q/132, createdBy=2afc101603, createdName=cat709394, createdTime=Tue Aug 20 18:32:29 CST 2024, time=2024-08-20, status=1, ipAttribution=辽宁)]

2021-08-29 胸外科小辣鸡

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肺癌
经验分享：第一次感受到审稿这么快的，一个月内找到两个审稿人，一个基本上是直接接收，一个给的小修，反修后大概过了23天，今天刚刚接收，这是比较顺利的一次投稿。关于肺癌一种类型的发病率和预后情况，写作比较常规。

174 19

展开19条回复

[GetPortalCommentsPageByObjectIdResponse(id=2180719, encodeId=85052180e1967, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;临床 经验分享：一篇手术方式相关的meta分析，投稿6个月后接收。整个过程很漫长，从格式审核，寻找编辑，寻找审稿人时间都很长，导致心力交瘁。期间给编辑部发过4次催稿信，回复都很类似，告诉会尽快安排审稿。投稿五月一审才回来，审稿人一个拒稿，一个小修，修改后最终接收。个人经验，如果着急不建议投该杂志；但能送外审的话，接收率还挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Jan 11 10:05:46 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2225232, encodeId=81f92225232ff, content=偏重的研究方向：诊断;clinical;癌症 经验分享：一审意见已经返回两周了，今天导师给编辑发了催稿信，希望能快点处理吧😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a6f9016255, createdName=ms9000000051824319, createdTime=Wed Sep 11 15:58:53 CST 2024, time=2024-09-11, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2208765, encodeId=67172208e6529, content=偏重的研究方向：肿瘤;临床 经验分享：1月5日 peer review到现在5个月状态一直没变中途写邮件问，回复说在努力寻找审稿人..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2115690790, createdName=ms5000000721393428, createdTime=Fri Jun 07 10:24:45 CST 2024, time=2024-06-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2223131, encodeId=ea6d222313176, content=太慢了，3个多月了，还在With editor , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a40c8345293, createdName=ms3000001689807175, createdTime=Thu Aug 29 22:52:35 CST 2024, time=2024-08-29, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143493, encodeId=a16e21434934c, content=偏重的研究方向：肺癌;乳腺癌;肿瘤免疫 经验分享：2023年3月20号投稿的，5月16号两个审稿意见都回来了，都是小修，5月30号修回，到现在没啥消息，心累, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef685682178, createdName=ms2000001828535543, createdTime=Sun Jun 18 12:41:51 CST 2023, time=2023-06-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1012596, encodeId=f2f71012596a4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：第一次感受到审稿这么快的，一个月内找到两个审稿人，一个基本上是直接接收，一个给的小修，反修后大概过了23天，今天刚刚接收，这是比较顺利的一次投稿。关于肺癌一种类型的发病率和预后情况，写作比较常规。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/c69458c5aae644fca7458ac4ee7d3dc5/97598ec05e2943409cd351605fd99203.jpg, createdBy=75b92509278, createdName=胸外科小辣鸡, createdTime=Sun Aug 29 16:55:52 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222496, encodeId=4186222249695, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：6.13投稿 6.14通过技术审查 6.14with editor 到现在中途催稿两次都说在帮我找编辑好好好这个杂志真的教我做人了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e99331389, createdName=ms8000001072402810, createdTime=Mon Aug 26 16:40:49 CST 2024, time=2024-08-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2223081, encodeId=8e25222308179, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Submission history Submission received Submission status Date Submission received 10 Nov 2023 Technical check Submission status Date Submission is under technical check 10 Nov 2023 Amendment requested 16 Nov 2023 Amendment received 17 Nov 2023 Amendment requested 23 Nov 2023 Amendment received 23 Nov 2023 Submission passed technical check 23 Nov 2023 Editorial assignment Submission status Date Ready for editorial assignment 23 Nov 2023 With editor Submission status Date Editor assigned 05 Jan 2024 Peer review Submission status Date First reviewer(s) invited 10 Jan 2024 Reviewer(s) accepted 12 Mar 2024 Reviewer report(s) received 16 Mar 2024 Revision requested 23 May 2024 Revision received 06 Jun 2024 Submission passed technical check 06 Jun 2024 First reviewer(s) invited 20 Jun 2024 Reviewer(s) accepted 08 Jul 2024 Reviewer report(s) received 23 Jul 2024 Revision requested 31 Jul 2024 Revision received 13 Aug 2024 Submission passed technical check 13 Aug 2024 Submission accepted Submission status Date Submission accepted 22 Aug 2024 Publishing and rights Submission status Date Submission is in publishing and rights, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Thu Aug 29 19:39:14 CST 2024, time=2024-08-29, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2223148, encodeId=8ad92223148e4, content=偏重的研究方向：肿瘤;食管癌 经验分享：The editor has received 2 reviewer report(s). 快一个月了，handing editor仍然没有做决定，各位有遇到过么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49f63034913, createdName=wangle9206, createdTime=Fri Aug 30 08:38:33 CST 2024, time=2024-08-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2221574, encodeId=7cdc22215e4fe, content=和大家分享一下，互勉 Submission history Submission received Submission status Date Submission received 22 Jan 2024 Technical check Submission status Date Submission is under technical check 22 Jan 2024 Amendment requested 01 Feb 2024 Amendment received 04 Feb 2024 Amendment requested 05 Feb 2024 Amendment received 08 Feb 2024 Submission passed technical check 12 Feb 2024 Editorial assignment Submission status Date Ready for editorial assignment 12 Feb 2024 With editor Submission status Date Editor assigned 12 Feb 2024 Peer review Submission status Date Reviewer(s) invited 23 Apr 2024 Reviewer(s) accepted 13 Jun 2024 Reviewer report(s) received 23 Jun 2024 Revision requested 07 Jul 2024 Revision received 18 Jul 2024 Submission passed technical check 19 Jul 2024 Reviewer(s) invited 24 Jul 2024 Reviewer(s) accepted 25 Jul 2024 Reviewer report(s) received 04 Aug 2024 Revision requested 05 Aug 2024 Revision received 09 Aug 2024 Submission passed technical check 09 Aug 2024 Reviewer(s) invited 11 Aug 2024 Reviewer(s) accepted 12 Aug 2024 Reviewer report(s) received 15 Aug 2024 Submission accepted Submission status Date Submission accepted 20 Aug 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TnBzsnIeibbibHtAcOogpwCUlK1FveaYBDibBmqrXZMdqc1mJHUXyrj8H988HwqdAUU2Q/132, createdBy=2afc101603, createdName=cat709394, createdTime=Tue Aug 20 18:32:29 CST 2024, time=2024-08-20, status=1, ipAttribution=辽宁)]

2024-08-26 ms8000001072402810 来自浙江省

审稿速度:24.0 | 投稿命中率:50.0
偏重的研究方向：肺癌
经验分享：6.13投稿 6.14通过技术审查 6.14with editor 到现在中途催稿两次都说在帮我找编辑好好好这个杂志真的教我做人了

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2180719, encodeId=85052180e1967, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;临床 经验分享：一篇手术方式相关的meta分析，投稿6个月后接收。整个过程很漫长，从格式审核，寻找编辑，寻找审稿人时间都很长，导致心力交瘁。期间给编辑部发过4次催稿信，回复都很类似，告诉会尽快安排审稿。投稿五月一审才回来，审稿人一个拒稿，一个小修，修改后最终接收。个人经验，如果着急不建议投该杂志；但能送外审的话，接收率还挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Jan 11 10:05:46 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2225232, encodeId=81f92225232ff, content=偏重的研究方向：诊断;clinical;癌症 经验分享：一审意见已经返回两周了，今天导师给编辑发了催稿信，希望能快点处理吧😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a6f9016255, createdName=ms9000000051824319, createdTime=Wed Sep 11 15:58:53 CST 2024, time=2024-09-11, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2208765, encodeId=67172208e6529, content=偏重的研究方向：肿瘤;临床 经验分享：1月5日 peer review到现在5个月状态一直没变中途写邮件问，回复说在努力寻找审稿人..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2115690790, createdName=ms5000000721393428, createdTime=Fri Jun 07 10:24:45 CST 2024, time=2024-06-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2223131, encodeId=ea6d222313176, content=太慢了，3个多月了，还在With editor , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a40c8345293, createdName=ms3000001689807175, createdTime=Thu Aug 29 22:52:35 CST 2024, time=2024-08-29, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143493, encodeId=a16e21434934c, content=偏重的研究方向：肺癌;乳腺癌;肿瘤免疫 经验分享：2023年3月20号投稿的，5月16号两个审稿意见都回来了，都是小修，5月30号修回，到现在没啥消息，心累, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef685682178, createdName=ms2000001828535543, createdTime=Sun Jun 18 12:41:51 CST 2023, time=2023-06-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1012596, encodeId=f2f71012596a4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：第一次感受到审稿这么快的，一个月内找到两个审稿人，一个基本上是直接接收，一个给的小修，反修后大概过了23天，今天刚刚接收，这是比较顺利的一次投稿。关于肺癌一种类型的发病率和预后情况，写作比较常规。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/c69458c5aae644fca7458ac4ee7d3dc5/97598ec05e2943409cd351605fd99203.jpg, createdBy=75b92509278, createdName=胸外科小辣鸡, createdTime=Sun Aug 29 16:55:52 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222496, encodeId=4186222249695, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：6.13投稿 6.14通过技术审查 6.14with editor 到现在中途催稿两次都说在帮我找编辑好好好这个杂志真的教我做人了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e99331389, createdName=ms8000001072402810, createdTime=Mon Aug 26 16:40:49 CST 2024, time=2024-08-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2223081, encodeId=8e25222308179, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Submission history Submission received Submission status Date Submission received 10 Nov 2023 Technical check Submission status Date Submission is under technical check 10 Nov 2023 Amendment requested 16 Nov 2023 Amendment received 17 Nov 2023 Amendment requested 23 Nov 2023 Amendment received 23 Nov 2023 Submission passed technical check 23 Nov 2023 Editorial assignment Submission status Date Ready for editorial assignment 23 Nov 2023 With editor Submission status Date Editor assigned 05 Jan 2024 Peer review Submission status Date First reviewer(s) invited 10 Jan 2024 Reviewer(s) accepted 12 Mar 2024 Reviewer report(s) received 16 Mar 2024 Revision requested 23 May 2024 Revision received 06 Jun 2024 Submission passed technical check 06 Jun 2024 First reviewer(s) invited 20 Jun 2024 Reviewer(s) accepted 08 Jul 2024 Reviewer report(s) received 23 Jul 2024 Revision requested 31 Jul 2024 Revision received 13 Aug 2024 Submission passed technical check 13 Aug 2024 Submission accepted Submission status Date Submission accepted 22 Aug 2024 Publishing and rights Submission status Date Submission is in publishing and rights, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Thu Aug 29 19:39:14 CST 2024, time=2024-08-29, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2223148, encodeId=8ad92223148e4, content=偏重的研究方向：肿瘤;食管癌 经验分享：The editor has received 2 reviewer report(s). 快一个月了，handing editor仍然没有做决定，各位有遇到过么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49f63034913, createdName=wangle9206, createdTime=Fri Aug 30 08:38:33 CST 2024, time=2024-08-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2221574, encodeId=7cdc22215e4fe, content=和大家分享一下，互勉 Submission history Submission received Submission status Date Submission received 22 Jan 2024 Technical check Submission status Date Submission is under technical check 22 Jan 2024 Amendment requested 01 Feb 2024 Amendment received 04 Feb 2024 Amendment requested 05 Feb 2024 Amendment received 08 Feb 2024 Submission passed technical check 12 Feb 2024 Editorial assignment Submission status Date Ready for editorial assignment 12 Feb 2024 With editor Submission status Date Editor assigned 12 Feb 2024 Peer review Submission status Date Reviewer(s) invited 23 Apr 2024 Reviewer(s) accepted 13 Jun 2024 Reviewer report(s) received 23 Jun 2024 Revision requested 07 Jul 2024 Revision received 18 Jul 2024 Submission passed technical check 19 Jul 2024 Reviewer(s) invited 24 Jul 2024 Reviewer(s) accepted 25 Jul 2024 Reviewer report(s) received 04 Aug 2024 Revision requested 05 Aug 2024 Revision received 09 Aug 2024 Submission passed technical check 09 Aug 2024 Reviewer(s) invited 11 Aug 2024 Reviewer(s) accepted 12 Aug 2024 Reviewer report(s) received 15 Aug 2024 Submission accepted Submission status Date Submission accepted 20 Aug 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TnBzsnIeibbibHtAcOogpwCUlK1FveaYBDibBmqrXZMdqc1mJHUXyrj8H988HwqdAUU2Q/132, createdBy=2afc101603, createdName=cat709394, createdTime=Tue Aug 20 18:32:29 CST 2024, time=2024-08-20, status=1, ipAttribution=辽宁)]

2024-08-29 好运好运来自内蒙古

审稿速度:2.0 | 投稿命中率:50.0
经验分享：Submission history
Submission received
Submission status Date
Submission received
10 Nov 2023
Technical check
Submission status Date
Submission is under technical check
10 Nov 2023
Amendment requested
16 Nov 2023
Amendment received
17 Nov 2023
Amendment requested
23 Nov 2023
Amendment received
23 Nov 2023
Submission passed technical check
23 Nov 2023
Editorial assignment
Submission status Date
Ready for editorial assignment
23 Nov 2023
With editor
Submission status Date
Editor assigned
05 Jan 2024
Peer review
Submission status Date
First reviewer(s) invited
10 Jan 2024
Reviewer(s) accepted
12 Mar 2024
Reviewer report(s) received
16 Mar 2024
Revision requested
23 May 2024
Revision received
06 Jun 2024
Submission passed technical check
06 Jun 2024
First reviewer(s) invited
20 Jun 2024
Reviewer(s) accepted
08 Jul 2024
Reviewer report(s) received
23 Jul 2024
Revision requested
31 Jul 2024
Revision received
13 Aug 2024
Submission passed technical check
13 Aug 2024
Submission accepted
Submission status Date
Submission accepted
22 Aug 2024
Publishing and rights
Submission status Date
Submission is in publishing and rights

38 0

[GetPortalCommentsPageByObjectIdResponse(id=2180719, encodeId=85052180e1967, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;临床 经验分享：一篇手术方式相关的meta分析，投稿6个月后接收。整个过程很漫长，从格式审核，寻找编辑，寻找审稿人时间都很长，导致心力交瘁。期间给编辑部发过4次催稿信，回复都很类似，告诉会尽快安排审稿。投稿五月一审才回来，审稿人一个拒稿，一个小修，修改后最终接收。个人经验，如果着急不建议投该杂志；但能送外审的话，接收率还挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Jan 11 10:05:46 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2225232, encodeId=81f92225232ff, content=偏重的研究方向：诊断;clinical;癌症 经验分享：一审意见已经返回两周了，今天导师给编辑发了催稿信，希望能快点处理吧😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a6f9016255, createdName=ms9000000051824319, createdTime=Wed Sep 11 15:58:53 CST 2024, time=2024-09-11, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2208765, encodeId=67172208e6529, content=偏重的研究方向：肿瘤;临床 经验分享：1月5日 peer review到现在5个月状态一直没变中途写邮件问，回复说在努力寻找审稿人..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2115690790, createdName=ms5000000721393428, createdTime=Fri Jun 07 10:24:45 CST 2024, time=2024-06-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2223131, encodeId=ea6d222313176, content=太慢了，3个多月了，还在With editor , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a40c8345293, createdName=ms3000001689807175, createdTime=Thu Aug 29 22:52:35 CST 2024, time=2024-08-29, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143493, encodeId=a16e21434934c, content=偏重的研究方向：肺癌;乳腺癌;肿瘤免疫 经验分享：2023年3月20号投稿的，5月16号两个审稿意见都回来了，都是小修，5月30号修回，到现在没啥消息，心累, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef685682178, createdName=ms2000001828535543, createdTime=Sun Jun 18 12:41:51 CST 2023, time=2023-06-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1012596, encodeId=f2f71012596a4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：第一次感受到审稿这么快的，一个月内找到两个审稿人，一个基本上是直接接收，一个给的小修，反修后大概过了23天，今天刚刚接收，这是比较顺利的一次投稿。关于肺癌一种类型的发病率和预后情况，写作比较常规。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/c69458c5aae644fca7458ac4ee7d3dc5/97598ec05e2943409cd351605fd99203.jpg, createdBy=75b92509278, createdName=胸外科小辣鸡, createdTime=Sun Aug 29 16:55:52 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222496, encodeId=4186222249695, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：6.13投稿 6.14通过技术审查 6.14with editor 到现在中途催稿两次都说在帮我找编辑好好好这个杂志真的教我做人了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e99331389, createdName=ms8000001072402810, createdTime=Mon Aug 26 16:40:49 CST 2024, time=2024-08-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2223081, encodeId=8e25222308179, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Submission history Submission received Submission status Date Submission received 10 Nov 2023 Technical check Submission status Date Submission is under technical check 10 Nov 2023 Amendment requested 16 Nov 2023 Amendment received 17 Nov 2023 Amendment requested 23 Nov 2023 Amendment received 23 Nov 2023 Submission passed technical check 23 Nov 2023 Editorial assignment Submission status Date Ready for editorial assignment 23 Nov 2023 With editor Submission status Date Editor assigned 05 Jan 2024 Peer review Submission status Date First reviewer(s) invited 10 Jan 2024 Reviewer(s) accepted 12 Mar 2024 Reviewer report(s) received 16 Mar 2024 Revision requested 23 May 2024 Revision received 06 Jun 2024 Submission passed technical check 06 Jun 2024 First reviewer(s) invited 20 Jun 2024 Reviewer(s) accepted 08 Jul 2024 Reviewer report(s) received 23 Jul 2024 Revision requested 31 Jul 2024 Revision received 13 Aug 2024 Submission passed technical check 13 Aug 2024 Submission accepted Submission status Date Submission accepted 22 Aug 2024 Publishing and rights Submission status Date Submission is in publishing and rights, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Thu Aug 29 19:39:14 CST 2024, time=2024-08-29, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2223148, encodeId=8ad92223148e4, content=偏重的研究方向：肿瘤;食管癌 经验分享：The editor has received 2 reviewer report(s). 快一个月了，handing editor仍然没有做决定，各位有遇到过么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49f63034913, createdName=wangle9206, createdTime=Fri Aug 30 08:38:33 CST 2024, time=2024-08-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2221574, encodeId=7cdc22215e4fe, content=和大家分享一下，互勉 Submission history Submission received Submission status Date Submission received 22 Jan 2024 Technical check Submission status Date Submission is under technical check 22 Jan 2024 Amendment requested 01 Feb 2024 Amendment received 04 Feb 2024 Amendment requested 05 Feb 2024 Amendment received 08 Feb 2024 Submission passed technical check 12 Feb 2024 Editorial assignment Submission status Date Ready for editorial assignment 12 Feb 2024 With editor Submission status Date Editor assigned 12 Feb 2024 Peer review Submission status Date Reviewer(s) invited 23 Apr 2024 Reviewer(s) accepted 13 Jun 2024 Reviewer report(s) received 23 Jun 2024 Revision requested 07 Jul 2024 Revision received 18 Jul 2024 Submission passed technical check 19 Jul 2024 Reviewer(s) invited 24 Jul 2024 Reviewer(s) accepted 25 Jul 2024 Reviewer report(s) received 04 Aug 2024 Revision requested 05 Aug 2024 Revision received 09 Aug 2024 Submission passed technical check 09 Aug 2024 Reviewer(s) invited 11 Aug 2024 Reviewer(s) accepted 12 Aug 2024 Reviewer report(s) received 15 Aug 2024 Submission accepted Submission status Date Submission accepted 20 Aug 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TnBzsnIeibbibHtAcOogpwCUlK1FveaYBDibBmqrXZMdqc1mJHUXyrj8H988HwqdAUU2Q/132, createdBy=2afc101603, createdName=cat709394, createdTime=Tue Aug 20 18:32:29 CST 2024, time=2024-08-20, status=1, ipAttribution=辽宁)]

2024-08-30 wangle9206 来自四川省

偏重的研究方向：肿瘤;食管癌
经验分享：The editor has received 2 reviewer report(s). 快一个月了，handing editor仍然没有做决定，各位有遇到过么？

32 0

[GetPortalCommentsPageByObjectIdResponse(id=2180719, encodeId=85052180e1967, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;临床 经验分享：一篇手术方式相关的meta分析，投稿6个月后接收。整个过程很漫长，从格式审核，寻找编辑，寻找审稿人时间都很长，导致心力交瘁。期间给编辑部发过4次催稿信，回复都很类似，告诉会尽快安排审稿。投稿五月一审才回来，审稿人一个拒稿，一个小修，修改后最终接收。个人经验，如果着急不建议投该杂志；但能送外审的话，接收率还挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Jan 11 10:05:46 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2225232, encodeId=81f92225232ff, content=偏重的研究方向：诊断;clinical;癌症 经验分享：一审意见已经返回两周了，今天导师给编辑发了催稿信，希望能快点处理吧😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a6f9016255, createdName=ms9000000051824319, createdTime=Wed Sep 11 15:58:53 CST 2024, time=2024-09-11, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2208765, encodeId=67172208e6529, content=偏重的研究方向：肿瘤;临床 经验分享：1月5日 peer review到现在5个月状态一直没变中途写邮件问，回复说在努力寻找审稿人..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2115690790, createdName=ms5000000721393428, createdTime=Fri Jun 07 10:24:45 CST 2024, time=2024-06-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2223131, encodeId=ea6d222313176, content=太慢了，3个多月了，还在With editor , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a40c8345293, createdName=ms3000001689807175, createdTime=Thu Aug 29 22:52:35 CST 2024, time=2024-08-29, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143493, encodeId=a16e21434934c, content=偏重的研究方向：肺癌;乳腺癌;肿瘤免疫 经验分享：2023年3月20号投稿的，5月16号两个审稿意见都回来了，都是小修，5月30号修回，到现在没啥消息，心累, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef685682178, createdName=ms2000001828535543, createdTime=Sun Jun 18 12:41:51 CST 2023, time=2023-06-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1012596, encodeId=f2f71012596a4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：第一次感受到审稿这么快的，一个月内找到两个审稿人，一个基本上是直接接收，一个给的小修，反修后大概过了23天，今天刚刚接收，这是比较顺利的一次投稿。关于肺癌一种类型的发病率和预后情况，写作比较常规。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/c69458c5aae644fca7458ac4ee7d3dc5/97598ec05e2943409cd351605fd99203.jpg, createdBy=75b92509278, createdName=胸外科小辣鸡, createdTime=Sun Aug 29 16:55:52 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222496, encodeId=4186222249695, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：6.13投稿 6.14通过技术审查 6.14with editor 到现在中途催稿两次都说在帮我找编辑好好好这个杂志真的教我做人了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e99331389, createdName=ms8000001072402810, createdTime=Mon Aug 26 16:40:49 CST 2024, time=2024-08-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2223081, encodeId=8e25222308179, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Submission history Submission received Submission status Date Submission received 10 Nov 2023 Technical check Submission status Date Submission is under technical check 10 Nov 2023 Amendment requested 16 Nov 2023 Amendment received 17 Nov 2023 Amendment requested 23 Nov 2023 Amendment received 23 Nov 2023 Submission passed technical check 23 Nov 2023 Editorial assignment Submission status Date Ready for editorial assignment 23 Nov 2023 With editor Submission status Date Editor assigned 05 Jan 2024 Peer review Submission status Date First reviewer(s) invited 10 Jan 2024 Reviewer(s) accepted 12 Mar 2024 Reviewer report(s) received 16 Mar 2024 Revision requested 23 May 2024 Revision received 06 Jun 2024 Submission passed technical check 06 Jun 2024 First reviewer(s) invited 20 Jun 2024 Reviewer(s) accepted 08 Jul 2024 Reviewer report(s) received 23 Jul 2024 Revision requested 31 Jul 2024 Revision received 13 Aug 2024 Submission passed technical check 13 Aug 2024 Submission accepted Submission status Date Submission accepted 22 Aug 2024 Publishing and rights Submission status Date Submission is in publishing and rights, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Thu Aug 29 19:39:14 CST 2024, time=2024-08-29, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2223148, encodeId=8ad92223148e4, content=偏重的研究方向：肿瘤;食管癌 经验分享：The editor has received 2 reviewer report(s). 快一个月了，handing editor仍然没有做决定，各位有遇到过么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49f63034913, createdName=wangle9206, createdTime=Fri Aug 30 08:38:33 CST 2024, time=2024-08-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2221574, encodeId=7cdc22215e4fe, content=和大家分享一下，互勉 Submission history Submission received Submission status Date Submission received 22 Jan 2024 Technical check Submission status Date Submission is under technical check 22 Jan 2024 Amendment requested 01 Feb 2024 Amendment received 04 Feb 2024 Amendment requested 05 Feb 2024 Amendment received 08 Feb 2024 Submission passed technical check 12 Feb 2024 Editorial assignment Submission status Date Ready for editorial assignment 12 Feb 2024 With editor Submission status Date Editor assigned 12 Feb 2024 Peer review Submission status Date Reviewer(s) invited 23 Apr 2024 Reviewer(s) accepted 13 Jun 2024 Reviewer report(s) received 23 Jun 2024 Revision requested 07 Jul 2024 Revision received 18 Jul 2024 Submission passed technical check 19 Jul 2024 Reviewer(s) invited 24 Jul 2024 Reviewer(s) accepted 25 Jul 2024 Reviewer report(s) received 04 Aug 2024 Revision requested 05 Aug 2024 Revision received 09 Aug 2024 Submission passed technical check 09 Aug 2024 Reviewer(s) invited 11 Aug 2024 Reviewer(s) accepted 12 Aug 2024 Reviewer report(s) received 15 Aug 2024 Submission accepted Submission status Date Submission accepted 20 Aug 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TnBzsnIeibbibHtAcOogpwCUlK1FveaYBDibBmqrXZMdqc1mJHUXyrj8H988HwqdAUU2Q/132, createdBy=2afc101603, createdName=cat709394, createdTime=Tue Aug 20 18:32:29 CST 2024, time=2024-08-20, status=1, ipAttribution=辽宁)]

2024-08-20 cat709394 来自辽宁

和大家分享一下，互勉 Submission history Submission received Submission status Date Submission received 22 Jan 2024 Technical check Submission status Date Submission is under technical check 22 Jan 2024 Amendment requested 01 Feb 2024 Amendment received 04 Feb 2024 Amendment requested 05 Feb 2024 Amendment received 08 Feb 2024 Submission passed technical check 12 Feb 2024 Editorial assignment Submission status Date Ready for editorial assignment 12 Feb 2024 With editor Submission status Date Editor assigned 12 Feb 2024 Peer review Submission status Date Reviewer(s) invited 23 Apr 2024 Reviewer(s) accepted 13 Jun 2024 Reviewer report(s) received 23 Jun 2024 Revision requested 07 Jul 2024 Revision received 18 Jul 2024 Submission passed technical check 19 Jul 2024 Reviewer(s) invited 24 Jul 2024 Reviewer(s) accepted 25 Jul 2024 Reviewer report(s) received 04 Aug 2024 Revision requested 05 Aug 2024 Revision received 09 Aug 2024 Submission passed technical check 09 Aug 2024 Reviewer(s) invited 11 Aug 2024 Reviewer(s) accepted 12 Aug 2024 Reviewer report(s) received 15 Aug 2024 Submission accepted Submission status Date Submission accepted 20 Aug 2024

63 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务